Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Sanofi-Aventis U.S. LLC, a prominent subsidiary of the global healthcare leader Sanofi, is headquartered in the United States, with significant operations across North America. Founded in 2004, the company has established itself within the pharmaceutical industry, focusing on innovative solutions in areas such as diabetes, cardiovascular health, and rare diseases.
Sanofi-Aventis is renowned for its diverse portfolio of core products, including insulin therapies and vaccines, which are distinguished by their commitment to patient-centric care and advanced research. The company has achieved notable milestones, including advancements in biologics and a strong market position as a trusted provider of essential medications. With a dedication to improving health outcomes, Sanofi-Aventis continues to play a vital role in the evolving landscape of global healthcare.
+58 vs industry average
Sanofi-Aventis U.S. LLC’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Sanofi-Aventis U.S. LLC yet.
Sanofi-Aventis U.S. LLC, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Sanofi, which cascades its climate commitments and emissions data from the parent organisation.
Sanofi has set various climate initiatives, including targets under the Science Based Targets initiative (SBTi), and participates in the Carbon Disclosure Project (CDP) and RE100, which focuses on renewable energy commitments. However, specific reduction targets or achievements for Sanofi-Aventis U.S. LLC are not detailed in the available information.
As a part of the broader Sanofi corporate family, the climate commitments and performance metrics are inherited from the parent company, Sanofi. This relationship underscores the importance of collective action within the pharmaceutical industry to address climate change and reduce carbon footprints.
No climate goals have been disclosed for Sanofi-Aventis U.S. LLC yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Sanofi-Aventis U.S. LLC yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more